Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Medline Industries, Inc., a leading name in the medical sector, is headquartered in the United States and operates extensively across North America and beyond. Founded in 1910, the company has established itself within the medical, precision, and optical instruments industry, focusing on the production and distribution of high-quality medical supplies and equipment.
Medline's core offerings include surgical instruments, wound care products, and infection prevention solutions, all designed to enhance patient care and operational efficiency in healthcare settings. The company is recognised for its commitment to innovation and quality, positioning itself as a trusted partner for healthcare providers. With a strong market presence and a reputation for excellence, Medline continues to achieve significant milestones, reinforcing its status as a leader in the medical supply industry.
71
DitchCarbon score
+39 vs industry average
Medline Industries’s score of 71 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Medline Industries?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Medical Device Manufacturing has below-average carbon intensity
Industry performance
0.308
20182025
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Medline Industries's reported carbon emissions
Medline Industries's emissions data is inherited from its parent company, Medline Industries, Inc.
For 2025, Medline Industries reported total emissions of approximately 7.77 billion kg CO2e. This includes Scope 1 emissions of about 151.65 million kg CO2e, Scope 2 emissions of around 136.80 million kg CO2e, and Scope 3 emissions totalling approximately 7.48 billion kg CO2e. Key contributors to Scope 3 emissions in 2025 were purchased goods and services (about 5.19 billion kg CO2e) and end-of-life treatment of sold products (around 1.26 billion kg CO2e).
In 2024, the company's total emissions were approximately 5.09 billion kg CO2e. This comprised Scope 1 emissions of about 133.23 million kg CO2e, Scope 2 emissions (market-based) of around 141.26 million kg CO2e, and Scope 3 emissions of approximately 4.81 billion kg CO2e. Purchased goods and services (about 3.14 billion kg CO2e) and end-of-life treatment of sold products (around 917.68 million kg CO2e) were significant Scope 3 categories.
In 2023, Medline Industries reported total emissions of approximately 7.28 billion kg CO2e. This included Scope 1 emissions of around 173.84 million kg CO2e, Scope 2 emissions of about 131.90 million kg CO2e, and Scope 3 emissions of approximately 6.97 billion kg CO2e. Purchased goods and services constituted the largest portion of Scope 3 emissions at about 5.68 billion kg CO2e.
Looking ahead, Medline Industries is committed to reducing its Scope 1 emissions by 30% from a 2023 baseline by 2030, and Scope 2 emissions by 30% from a 2023 baseline by 2030. The company also aims to reduce its Scope 1 and 2 emissions to near zero by mid-decade (2025). Furthermore, Medline Industries Ltd (a subsidiary) aims for an absolute reduction of 42% in Scope 1 and 2 emissions and a 25% absolute reduction in Scope 3 emissions by 2030, using a 2022 baseline. The company has a long-term commitment to achieving Net Zero emissions across all scopes by 2050.
Assessing Medline Industries as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Medline Industries and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Medline Industries’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
8 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Medline Industries5 months ago
71
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more